Zacks Investment Research on MSN
Amgen strikes drug pricing deal with Trump: What investors should know
Amgen AMGN recently signed a landmark agreement with the Trump administration to lower drug prices in the United States. Through this deal, Amgen addresses the two major concerns that have plagued Big ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results